Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-30
2006-05-30
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S317000
Reexamination Certificate
active
07053047
ABSTRACT:
This invention relates to cyclic peptides, with the following formula (I) (SEQ ID NO: 1),in-line-formulae description="In-line Formulae" end="lead"?cyclo(Xaa-Arg-Pro-Ala-Lys) (I)in-line-formulae description="In-line Formulae" end="tail"?where Xaa is Ala, Gly, Glu, Gln, Asp, Asn, Arg or Lys. The cyclic peptides have thrombolytic effects. This invention also relates to cyclic peptide preparations.
REFERENCES:
patent: 5514590 (1996-05-01), Garvin et al.
patent: WO 00/75176 (2000-12-01), None
Yin-Ye Wang, Ming Zhao, Shi-Qi Peng, Chang-Ling Li, Qin-Lu Zhou and Qiang Li, “The Antithrombotic Effects of P6A and its Derivatives”, Journal of Chinese Pharmaceutical Sciences 1996, 5 (4), pp. 174-176.
Na Lin
Peng Shigi
Wang Chao
Zhao Ming
Bacon & Thomas
Campell Bruce R.
Gudibande Satyanarayana R.
Purzer Pharmaceutical Co., Ltd.
LandOfFree
Cyclic pentapeptides and their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic pentapeptides and their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic pentapeptides and their preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3592373